Renal Function in Type 2 Diabetes with Rosiglitazone, Metformin, and Glyburide Monotherapy

SUMMARY: BACKGROUND AND OBJECTIVES: In ADOPT (A Diabetes Outcomes Prevention Trial), initial monotherapy with rosiglitazone provided more durable glycemic control than metformin or glyburide in patients with recently diagnosed type 2 diabetes. Herein, we examine differences in albumin excretion, ren...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Lachin, John M., Viberti, Giancarlo, Zinman, Bernard, Haffner, Steven M., Aftring, R. Paul, Paul, Gitanjali, Kravitz, Barbara G., Herman, William H., Holman, Rury R., Kahn, Steven E.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American Society of Nephrology 2011
Pynciau:
Original Articles
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3087768/
https://ncbi.nlm.nih.gov/pubmed/21454723
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.09291010
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg